Pulmonary mycosis in patients with diabetes mellitus. Clinical characteristics and risk factors

被引:5
作者
Hernandez-Solis, Alejandro [1 ]
Camerino Guerrero, Alejandra [1 ]
Colin Munoz, Yesenia [1 ]
Bazan Cuervo, Saret [1 ]
Cicero Sabido, Raul [1 ]
Reding-Bernal, Arturo [2 ]
机构
[1] Hosp Gen Mexico Dr Eduardo Liceaga, Unidad Neumol & Cirugia Torax, Mexico City, DF, Mexico
[2] Hosp Gen Mexico Dr Eduardo Liceaga, Direcc Invest, Mexico City, DF, Mexico
来源
REVISTA IBEROAMERICANA DE MICOLOGIA | 2020年 / 37卷 / 02期
关键词
Diabetes mellitus; Pulmonary mycoses; Tuberculosis; Histoplasmosis; EPIDEMIOLOGY; INFECTIONS;
D O I
10.1016/j.riam.2020.04.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Diabetes mellitus is a public health problem in Mexico, and the trend of the disease is increasing. From 2000 to 2017, 7.32 million new cases were diagnosed, with pulmonary mycoses being one of the most serious complications. Aims: To describe the frequency and the clinical characteristics of patients diagnosed with pulmonary mycoses, and to identify the risk factors associated with this entity. Methods: Case-control study, paired by gender (1:1-3) and age (+/- 5 years), that analyzed patients with pulmonary mycosis (mucormycosis, histoplasmosis, coccidioidomycosis, blastomycosis, aspergillosis, cryptococcosis, paracoccidioidomycosis) and studied the risk factors present in each patient. Results: From the 162 patients studied, 56 suffered pulmonary mycosis and 106 were controls. The median of the age was 51 and 50 years for the cases and for the controls, respectively. Multiple logistic regression analysis showed that patients with diabetes mellitus had an odds ratio of 8,3 (p < 0.001), and patients with a history of tuberculosis had an odds ratio of 8,8 (p < 0.001). Conclusions: Our results show that 52% of the patients with pulmonary mycoses had a history of diabetes mellitus. Diabetes mellitus is a relevant risk factor for pulmonary mycoses, which are usually diagnosed in advanced stages and have a high mortality. (C) 2020 Asociacion Espanola de Micologla. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 21 条
[1]  
Bazan ME, 2017, TIP REV ESP CIENC QU, V20, P48
[2]  
Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
[3]  
Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253
[4]   Epidemiology of endemic systemic fungal infections in Latin America [J].
Colombo, Arnaldo Lopes ;
Tobon, Angela ;
Restrepo, Angela ;
Queiroz-Telles, Flavio ;
Nucci, Marcio .
MEDICAL MYCOLOGY, 2011, 49 (08) :785-798
[5]   Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses [J].
Curbelo, Jose ;
Maria Galvan, Jose ;
Aspa, Javier .
ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (12) :647-653
[6]   Pulmonary and sinus fungal diseases in non-immunocompromised patients [J].
Denning, David W. ;
Chakrabarti, Arunaloke .
LANCET INFECTIOUS DISEASES, 2017, 17 (11) :E357-E366
[7]   Endemic pulmonary fungal diseases in immunocompetent patients: an emphasis on thoracic imaging [J].
Di Mango, Ana Luiza ;
Zanetti, Glaucia ;
Penha, Diana ;
Barreto, Miriam Menna ;
Marchiori, Edson .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (03) :263-277
[8]  
Dos Santos SS, 2018, J DIABETES RES, P1
[9]  
Garnacho-Montero J, 2013, REV ESP QUIM, V26, P173
[10]  
Gaytan HD, 2017, Rev. Panam. Salud Publica, V41